The use of liposomal enrofloxacin for intracellular infections in kangal dogs and visualization of phagocytosis of liposomes

Journal of Biomedical Materials Research

Volumn 61, Issue 2, 2002, Pages 246-251

  Deim, Zelihagül ^a   Deim, Tuncer ^a   Bas, Levent ^b   Elmas, Muammer ^b  

^a GAZI UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Enrofloxacin; Liposomes; Macrophages; Phagocytosis

Indexed keywords

ANTIBIOTICS; DRUG DOSAGE; MICROORGANISMS; MICROSCOPIC EXAMINATION;

MICROBICIDAL ACTIVITIES;

CELLS;

ANTIBIOTIC AGENT; ENROFLOXACIN; LIPOSOMAL ENROFLOXACIN; LIPOSOME; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; DRUG CARRIER; QUINOLONE DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; BACTERIAL INFECTION; BACTERIUM ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG FORMULATION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG DISEASE; DRUG EFFECT; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DOG DISEASES; DOGS; DRUG CARRIERS; FLUOROQUINOLONES; LIPOSOMES; MACROPHAGES; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; QUINOLONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0036269062     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.10161     Document Type: Conference Paper

References (24)

1. Mycobacteria other than Mycobacterium tuberculosis: Review of microbiologic and clinical aspects
2. Official statement of the American Thoracic Society. Diagnosis and treatment of diseases caused by nontuberculous mycobacteria
3. In-vitro effects of liposome-encapsulated amphotericin B (AmBiosome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes
4. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex
5. Multiple drug resistance in mycobacterium: Is the cell wall architecture responsible for the exclusion of antimicrobial agents?
6. Mycobacterium avium-M. Intracellulare: Rational therapy of chronic pulmonary infection
7. Activities of claritromycin, azitromycin and oflaxacin in combination with liposomal or unencapsulated granulocyte macrophage colony stimulating factor against intramacrophage mycobacterium avium-mycobacterium intracellulare
8. Kell phenotypes in chronic granulomatous diseases: A potential transfusion hazard
9. Treatment of murine cryptococcosis with liposome associated amphotericin
10. Enhanced intracellular killing of Streptococcus aureus by canine monocytes treated with liposome containing amikacin, kanamicin and tobramicin
11. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome encapsulated amphotericin
12. In-vitro and ex vivo enhancement of non specific phagocytosis by cefodizime
13. Diffusion of univalent ions across the lamellae of swollen phospholipids
14. The determination of liposome captured volume
15. High performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue
16. Sustained release of liposome-encapsulated Enrofloxacin after intramuscular administration in rabbits
17. Staphylococcus aureus isolation from the lesions, the hands, and anterior nares of patients with atopic dermatitis
18. Staphylococcus aureus isolation from the lesions, the hands, and anterior nares of patients with atopic dermatitis
19. Purification and properties of a bacteriocin of staphylococcus epidermitis isolated from dental plaque
20. Enhanced activity of mouse peritoneal cells after aclacinomycin administration
21. A rapid micro method for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitro
22. Use of liposome preparation to treat mycobacterial infections
23. Complement dependent phagocytosis of liposomes by macrophages: Suppressive affects of stealth lipids
24. Complement dependent phagocytosis of liposomes